"Having an objective, quantitative way to grade bladder cancers will help urologists provide personalized care matched to their patients’ individual risks.”
Dr. Berman (QCRI Director 2015-2021) received a 2-year funding award through OICR's Innovation to Implementation (I2I) program. Read more about this exciting news in today's OICR News Release here!